7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 
      
                
      assets
                
      current assets:
                
      cash and cash equivalents
    217,597,000 101,788,000 165,007,000 114,091,000 97,274,000 67,856,000 90,418,000 49,304,000 86,300,000 101,140,000 138,246,000 87,701,000 
      investments
    376,031,000 223,128,000 178,019,000 84,096,000 166,329,000 243,259,000 248,147,000 187,263,000 167,461,000 159,957,000 132,393,000  
      prepaid and other current assets
    6,168,000 10,353,000 11,480,000 7,164,000 4,129,000 6,886,000 8,254,000 12,536,000 11,614,000 8,391,000 4,635,000 2,701,000 
      total current assets
    599,796,000 335,269,000 354,506,000 205,351,000 267,732,000 318,001,000 346,819,000 249,103,000 265,375,000 269,488,000 275,274,000 112,811,000 
      property and equipment
    7,000 22,000 38,000 53,000 69,000 42,000 51,000      
      other assets
    144,000 433,000 397,000 499,000 452,000 449,000 379,000 51,000 51,000 51,000 39,000 1,631,000 
      total assets
    599,947,000 335,724,000 354,941,000 205,903,000 268,253,000 318,492,000 347,249,000 251,636,000 277,555,000 291,217,000 306,435,000 114,442,000 
      liabilities and stockholders’ equity
                
      current liabilities:
                
      accounts payable
    1,121,000 3,164,000 373,000 479,000 3,106,000 1,707,000 4,261,000 601,000 5,573,000 2,196,000 2,387,000 1,907,000 
      accrued liabilities
    22,399,000 19,009,000 13,013,000 14,167,000 28,215,000 26,690,000 14,943,000 9,881,000 7,970,000 4,011,000 8,173,000 6,160,000 
      total current liabilities
    23,520,000 22,173,000 13,386,000 14,646,000 31,321,000 28,397,000 19,204,000 10,482,000 13,543,000 6,207,000 10,560,000 8,067,000 
      commitments and contingencies
                
      stockholders’ equity:
                
      common stock
    8,000 6,000 6,000 5,000 5,000 5,000 5,000 4,000 4,000 4,000 4,000 1,000 
      additional paid-in capital
    1,001,354,000 701,548,000 686,278,000 493,770,000 490,499,000 487,320,000 484,256,000 365,858,000 364,327,000 362,565,000 361,289,000 540,000 
      accumulated deficit
    -424,935,000 -388,003,000 -344,729,000 -302,518,000 -253,572,000 -197,230,000 -156,216,000 -124,708,000 -100,319,000 -77,559,000 -65,418,000 -52,810,000 
      total stockholders’ equity
    576,427,000 313,551,000 341,555,000 191,257,000 236,932,000 290,095,000 328,045,000 241,154,000 264,012,000 285,010,000 295,875,000  
      total liabilities and stockholders’ equity
    599,947,000 335,724,000 354,941,000 205,903,000 268,253,000 318,492,000 347,249,000      
      investments, noncurrent
           2,482,000 12,129,000 21,678,000 31,122,000  
      liabilities, convertible preferred stock, and stockholders’ equity
                
      series a convertible preferred stock, 0.0001 par value, 0 and 86,332,216 shares authorized and 0 and 86,332,216 shares issued and outstanding as of december 31, 2023 and 2022, respectively, 0 and 41,180 aggregate liquidation preference as of december 31, 2023 and 2022, respectively
                
      series b convertible preferred stock, 0.0001 par value, 0 and 136,510,868 shares authorized and 0 and 136,510,868 shares issued and outstanding as of december 31, 2023 and 2022, respectively, 0 and 118,000 aggregate liquidation preference as of december 31, 2023 and 2022, respectively
                
      stockholders’ equity
                
      total liabilities, convertible preferred stock, and stockholders’ equity
           251,636,000 277,555,000 291,217,000 306,435,000  
      series a convertible preferred stock, 0.0001 par value, 0 and 86,332,216 shares authorized and 0 and 86,332,216 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively, 0 and 41,180 aggregate liquidation preference as of september 30, 2023 and december 31, 2022, respectively
                
      series b convertible preferred stock, 0.0001 par value, 0 and 136,510,868 shares authorized and 0 and 136,510,868 shares issued and outstanding as of september 30, 2023 and december 31, 2022, respectively, 0 and 118,000 aggregate liquidation preference as of september 30, 2023 and december 31, 2022, respectively
                
      series a convertible preferred stock, 0.0001 par value, 0 and 86,332,216 shares authorized and 0 and 86,332,216 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively, 0 and 41,180 aggregate liquidation preference as of june 30, 2023 and december 31, 2022, respectively
                
      series b convertible preferred stock, 0.0001 par value, 0 and 136,510,868 shares authorized and 0 and 136,510,868 shares issued and outstanding as of june 30, 2023 and december 31, 2022, respectively, 0 and 118,000 aggregate liquidation preference as of june 30, 2023 and december 31, 2022, respectively
                
      series a convertible preferred stock, 0.0001 par value, 0 and 86,332,216 shares authorized and 0 and 86,332,216 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively, 0 and 41,180 aggregate liquidation preference as of march 31, 2023 and december 31, 2022, respectively
                
      series b convertible preferred stock, 0.0001 par value, 0 and 136,510,868 shares authorized and 0 and 136,510,868 shares issued and outstanding as of march 31, 2023 and december 31, 2022, respectively, 0 and 118,000 aggregate liquidation preference as of march 31, 2023 and december 31, 2022, respectively
                
      marketable securities
               22,409,000 
      liabilities, convertible preferred stock, and stockholders’ deficit
                
      series a convertible preferred stock, 0.0001 par value, 86,332,216 and 86,340,911 shares authorized and 86,332,216 and 61,180,259 shares issued and outstanding as of december 31, 2022 and 2021, respectively, 41,180 and 29,184 aggregate liquidation preference as of december 31, 2022 and 2021, respectively
               40,987,000 
      series b convertible preferred stock, 0.0001 par value, 136,510,868 and 0 shares authorized and 136,510,868 and 0 shares issued and outstanding as of december 31, 2022 and 2021, respectively, 118,000 and 0 aggregate liquidation preference as of december 31, 2022 and 2021, respectively
               117,657,000 
      stockholders’ deficit:
                
      total stockholders’ deficit
               -52,269,000 
      total liabilities, convertible preferred stock, and stockholders’ deficit
               114,442,000 
      operating expenses:
                
      research and development
               26,250,000 
      general and administrative
               5,229,000 
      total operating expenses
               31,479,000 
      income from operations
               -31,479,000 
      other income:
                
      interest income
               1,676,000 
      change in fair value of convertible notes
                
      other income
               4,000 
      total other income
               1,680,000 
      net income
               -29,799,000 
      net income per share
               -5,770 
      weighted-average shares used for eps calculation
               5,167,296,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.